M2 Presswire - Bellwether Report.com Issues Alert for Labopharm Inc.
M2 PRESSWIRE-29 September 2006-bellwetherreport.com: Bellwether Report.com Issues Alert for Labopharm Inc.(C)1994-2006 M2 COMMUNICATIONS LTD RDATE:29092009 Bellwether Report Takes Notice of Labopharm Inc. (NASDAQ:DDSS) The company creates controlled-release drug delivery systems to turn new and existing drugs into once-a-day formulations.
Related Results
Hallucinations associated with initiation of guanfacine.(Letters to the Edito…
Labopharm Initiates Phase III Clinical Study for Once-Daily Formulation of Tr…
Impotence and hypnosis
Trazodone
URL Mutual Unveils Unit-of-Use Initiative.(United Research Laboratories and M…
Its platform product Contramid is a controlled-release system for oral solid dosage forms. Products using Contramid include Sanofi-Aventis’ allergy drug Allegra-D, Axcan Pharma’s irritable bowel syndrome drug Modulon, and Gruppo Agelini’s …
Read the rest of this article with a Free Trial at HighBeam Research.
